Mar 31, 2019

Gilead Sciences Q1 2019 Earnings Report

Total Revenue
$5.28B
Previous year: $5.09B
+3.8%
EPS
$1.76
Previous year: $1.48
+18.9%
Product gross margin
81.6%
Gross Profit
$4.32B
Previous year: $4.09B
+5.8%
Cash and Equivalents
$16.9B
Previous year: $7.64B
+121.5%
Free Cash Flow
$1.34B
Previous year: $2.06B
-34.9%
Total Assets
$62.8B
Previous year: $65.4B
-3.9%

Gilead Sciences

Gilead Sciences

Gilead Sciences Revenue by Segment

Gilead Sciences Revenue by Geographic Location